MetLife Investment Management
GH icon

MetLife Investment Management’s Guardant Health GH Stock Holding History

MetLife Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$978K Sell
6,517
-61,308
-90% -$6.67M ﹤0.01% 1537
2026
Q1 		$6.26M Buy
67,825
+903
+1% +$90.7K 0.03% 526
2025
Q4 		$6.84M Sell
66,922
-3,135
-4% -$280K 0.03% 487
2025
Q3 		$4.38M Sell
70,057
-1,063
-1% -$57.8K 0.02% 692
2025
Q2 		$3.7M Buy
71,120
+947
+1% +$42.3K 0.02% 700
2025
Q1 		$2.99M Sell
70,173
-1,976
-3% -$85.3K 0.02% 853
2024
Q4 		$2.2M Buy
72,149
+4,002
+6% +$113K 0.01% 985
2024
Q3 		$1.56M Hold
68,147
– – 0.01% 1151
2024
Q2 		$1.97M Buy
68,147
+9,542
+16% +$222K 0.01% 980
2024
Q1 		$1.21M Hold
58,605
– – 0.01% 1197
2023
Q4 		$1.59M Hold
58,605
– – 0.01% 1057
2023
Q3 		$1.74M Hold
58,605
– – 0.01% 966
2023
Q2 		$2.1M Buy
58,605
+52,701
+893% +$1.51M 0.02% 916
2023
Q1 		$138K Buy
5,904
+13
+0.2% +$371 ﹤0.01% 2420
2022
Q4 		$160K Sell
5,891
-155
-3% -$7.09K ﹤0.01% 2381
2022
Q3 		$325K Buy
6,046
+5
+0.1% +$257 ﹤0.01% 1944
2022
Q2 		$244K Buy
6,041
+230
+4% +$11.4K ﹤0.01% 2175
2022
Q1 		$385K Buy
+5,811
New +$398K ﹤0.01% 1943
2020
Q1 		– Sell
-3,147
Closed -$241K – 2266
2019
Q4 		$246K Buy
+3,147
New +$227K ﹤0.01% 1868
2019
Q3 		– Sell
-6,515
Closed -$562K – 2355
2019
Q2 		$562K Sell
6,515
-13,030
-67% -$995K 0.01% 1410
2019
Q1 		$1.5M Buy
19,545
+10,923
+127% +$606K ﹤0.01% 1428
2018
Q4 		$324K Buy
+8,622
New +$318K ﹤0.01% 1626

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

MetLife Investment Management's GH Position: Q2 2026 in Review

MetLife Investment Management reduced its Guardant Health (GH) stake by 90% in Q2 2026, selling an estimated $6.67M and leaving 6,517 shares worth $978K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.

MetLife Investment Management first reported a position in GH in Q4 2018 and has held it in 22 quarters since. The position peaked at $6.84M in Q4 2025. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • MetLife Investment Management held 6,517 shares of Guardant Health worth $978K as of Q2 2026.
  • MetLife Investment Management sold 61,308 Guardant Health shares in Q2 2026, an estimated $6.67M.
  • Guardant Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1537 holding.
  • MetLife Investment Management first reported a position in Guardant Health in Q4 2018 and has held it in 22 quarters since.
  • MetLife Investment Management's Guardant Health position peaked at $6.84M in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.